New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 19, 2013
07:36 EDTRTIX, BONE, CNMD, ZMH, OFIX, VSCI, ARTC, OSIRCanaccord to host a conference
Musculoskeletal Conference is being held in Chicago on March 19.
Sign up for a free trial to see the rest of the stories you've been missing.
February 11, 2016
16:30 EDTRTIXRTI Surgical announces agreement with Oxford Performance Materials
RTI Surgical announced a new agreement with Oxford Performance Materials, or OPM, a pioneer in advanced materials and additive manufacturing for biomedical applications. The agreement, effective Feb. 4, 2016, grants RTI an exclusive license to OPM's OsteoFab technology platform for spinal applications in all U.S. markets. OsteoFab is a next-generation implant manufacturing process that builds implantable medical devices, layer-by-layer, using only laser light and OPM's OXPEKK polymer. The OsteoFab process and OXPEKK material combine to create implants that are designed to enable bone ongrowth. OXPEKK is a proprietary high-performance biocompatible polymer formulation from OPM, designed for medical applications. This strong, pure, radiolucent, hydrophilic, load-bearing material boasts a successful history in orthopedic implant applications. Under the agreement, OPM will manufacture RTI's spinal implant designs using OsteoFab technology, and RTI will oversee finishing steps, packaging, marketing and distribution of finished products.
February 4, 2016
07:25 EDTOSIROsiris price target lowered to $4 from $8 at Brean Capital
Subscribe for More Information
February 3, 2016
16:34 EDTOSIROsiris appoints Chief Business OfficerDwayne Montgomery as Interim CEO
Subscribe for More Information
February 2, 2016
11:03 EDTOSIROsiris price target lowered to $18.50 from $28 at Piper Jaffray
Subscribe for More Information
08:01 EDTOSIROsiris announces 100% Medicare coverage for Grafix
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use